Awadzi K.
30
Coauthors
3
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Infección | 2 |
| Inmunología | 2 |
| Salud Pública | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 2 |
| Enfermedades | 2 |
| Medicina forense; incidencia de enfermedades | 1 |
| Problemas sociales y servicios a grupos | 1 |
| Fisiología humana | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 3 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Ottesen E.A. | 2 |
| Philip John Cooper | 2 |
| Nutman T.B. | 2 |
| Gyapong J.O. | 1 |
| Jayakody R.L. | 1 |
| Addiss D.G. | 1 |
| Weerasooriya M.V. | 1 |
| Dunyo S.K. | 1 |
| Selve B. | 1 |
| Beach M.J. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin
ArticleAbstract: To investigate the role of eosinophil activation and sequestration in the development and severity oPalabras claves:Autores:Awadzi K., Nutman T.B., Ottesen E.A., Philip John Cooper, Remick D.G.Fuentes:scopusAssociation of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin
ArticleAbstract: To investigate the role of mast cells in treatment-associated adverse reactions in patients with oncPalabras claves:Autores:Awadzi K., Guderian R.H., Irani A.M., Nutman T.B., Philip John Cooper, Schwartz L.B.Fuentes:scopusAn analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis
ReviewAbstract: This review of the safety of the co-administration regimens to be used in programmes to eliminate lyPalabras claves:Adverse events, albendazole, Brugia malayi, DEC, Diethylcarbamazine, Drug regimens for LF, drug safety, Ivermectin, Lymphatic filariasis, Programme to Eliminate Lymphatic Filariasis (PELF), Tropical disease control, Wuchereria bancroftiAutores:Addiss D.G., Awadzi K., Beach M.J., Belizario V.Y., Dunyo S.K., Gyapong J.O., Horton J., Hossain M., Ismail M.M., Jayakody R.L., Lammie P.J., Lazdins J.K., Makunde W., Mauricio Espinel, Ottesen E.A., Richard-Lenoble D., Selve B., Shenoy R.K., Simonsen P.E., Wamae C.N., Weerasooriya M.V., Witt C.Fuentes:scopus